New Publications from Mass General Psychiatry – September 29, 2023

The Mass General Department of Psychiatry encompasses more than 60 specialty integrated clinical and research programs.  Our wide-ranging research portfolio spans clinical and basic research covering virtually every major psychiatric disorder, as well as the psychiatric consequences of medical illness. 

These initiatives have led to notable expansions in genetics, neuroimaging and basic neuroscience, and this model of cross-talk between clinical care and science has consistently led to research advances that inform and advance clinical care.

The challenges of defining and managing treatment-resistant depression in research and practice.

Fava M.  World Psychiatry. 2023 Oct;22(3):350-351. 

Association of Osteoarthritis and Functional Limitations With Cognitive Impairment Among Older Adults in the United States.

Rakutt MJ, Mace RA, Conley CEW, Stone AV, Duncan ST, Greenberg J, Landy DC, Vranceanu AM, Jacobs CA. J Aging Health. 2023 Oct;35(9):643-650. 

Addressing the Chronic Pain-Early Cognitive Decline Comorbidity Among Older Adults: Protocol for the Active Brains Remote Efficacy Trial.

Vranceanu AM, Choukas NR, Rochon EA, Duarte B, Pietrzykowski MO, McDermott K, Hooker JE, Kulich R, Quiroz YT, Parker RA, Macklin EA, Ritchie C; Active Brains Project; Mace RA.  JMIR Res Protoc. 2023 Sep 28;12:e47319. 

Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders.

Lizano P, Pong S, Santarriaga S, Bannai D, Karmacharya R.  Mol Psychiatry. 2023 Sep 20. 

Addressing chronic pain disparities between Black and White people: a narrative review of socio-ecological determinants.

Pham TV, Doorley J, Kenney M, Joo JH, Shallcross AJ, Kincade M, Jackson J, Vranceanu AM.  Pain Manag. 2023 Aug 31. 

Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.

Riesenberg R, Yeung PP, Rekeda L, Sachs GS, Kerolous M, Fava M.  J Clin Psychiatry. 2023 Aug 16;84(5):22m14643. 

A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression.

Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X.  Int J Mol Sci. 2023 Aug 7;24(15):12513. 

Advanced Research Institute (ARI): Supporting the Geriatric Mental Health Research Pipeline.

Sirey JA, Pepin R, Aizenstein H, Taylor WD, Forester B, Okereke O, Byers AL, Bruce ML. Am J Geriatr Psychiatry. 2023 Aug 5:S1064-7481(23)00374-3. 

Advancing Excellence in Transgender Health: An International Professional Development Conference on Affirming Care for Transgender and Gender Diverse People.

Mitnick S, Goldhammer H, Thompson J, Bruno J, Dunn M, Reisner SL, Keuroghlian AS. J Med Educ Curric Dev. 2023 Jul 31.

“Alone in the dark”: A qualitative study of treatment experiences among young adults with a recent concussion and anxiety.

Lovette BC, Kanaya MR, Grunberg VA, McKinnon E, Vranceanu AM, Greenberg J.  Neuropsychol Rehabil. 2023 Jul 27:1-21. 

Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era.

Ma J, Luu B, Ruderman SA, Whitney BM, Merrill JO, Mixson LS, Nance RM, Drumright LN, Hahn AW, Fredericksen RJ, Chander G, Lau B, McCaul ME, Safren S, O’Cleirigh C, Cropsey K, Mayer KH, Mathews WC, Moore RD, Napravnik S, Christopoulos K, Willig A, Jacobson JM, Webel A, Burkholder G, Mugavero MJ, Saag MS, Kitahata MM, Crane HM, Delaney JAC.  AIDS Care. 2023 Jul 7:1-13. 

Breaking the Disability Spiral: A Case Series Report Illustrating the Delivery of a Brief Skills Based Coaching Intervention to Prevent Chronic Dysfunction and Pain After Orthopedic Injury.

Duarte BA, Mace RA, Doorley JD, Penn TM, Bakhshaie J, Vranceanu AM.  J Clin Psychol Med Settings. 2023 May 30. 

A Bipolar Learning Health Network: An innovation whose time has come.

Nierenberg AA, Margolis P, Strakowski S, Trivedi M, Yatham LN; Bipolar Disorder Learning Health Network.  Bipolar Disord. 2023 May;25(3):177-180. 

AI-assisted prediction of differential response to antidepressant classes using electronic health records.

Sheu YH, Magdamo C, Miller M, Das S, Blacker D, Smoller JW.  NPJ Digit Med. 2023 Apr 26;6(1):73. 

Artificial Intelligence-Based Major Depressive Disorder (MDD) Diagnosis Using Raman Spectroscopic Features of Plasma Exosomes.

Shin H, Kang Y, Choi KW, Kim S, Ham BJ, Choi Y.  Anal Chem. 2023 Apr 18;95(15):6410-6416. 

Alternative psychopharmacologic treatments for pediatric catatonia: a retrospective analysis.

Smith JR, Baldwin I, York T, Anderson C, McGonigle T, Vandekar S, Wachtel L, Luccarelli J.  Front Child Adolesc Psychiatry. 2023;2:1208926.